• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $TVGN

    Tevogen Bio Holdings Inc.

    Subscribe to $TVGN
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IPO Year: 2022

    Exchange: NASDAQ

    Recent Analyst Ratings for Tevogen Bio Holdings Inc.

    DatePrice TargetRatingAnalyst
    3/4/2025$10.00Buy
    D. Boral Capital
    See more ratings

    Tevogen Bio Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Saadi Ryan H. sold $1,768,993 worth of shares (1,438,206 units at $1.23), decreasing direct ownership by 1% to 116,814,453 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      6/9/25 7:13:44 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Officer Flomenberg Neal sold $253,935 worth of shares (232,968 units at $1.09), decreasing direct ownership by 6% to 3,595,608 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      3/14/25 9:02:55 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Officer Flomenberg Neal sold $231,734 worth of shares (211,909 units at $1.09), decreasing direct ownership by 5% to 3,828,576 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      3/11/25 8:52:08 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Officer Flomenberg Neal sold $250,006 worth of shares (213,817 units at $1.17), decreasing direct ownership by 5% to 4,040,485 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      3/6/25 9:41:49 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Feike Jeffrey L. was granted 240,000 shares, increasing direct ownership by 41% to 821,771 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      12/26/24 6:36:28 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Patton Curtis L. was granted 240,000 shares, increasing direct ownership by 25% to 1,209,618 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      12/26/24 6:35:34 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Podlogar Susan M was granted 240,000 shares, increasing direct ownership by 124% to 433,923 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      12/26/24 6:33:58 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Sordillo Victor J. was granted 480,000 shares, increasing direct ownership by 495% to 576,962 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      12/26/24 6:30:37 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Goh Keow Lin was granted 240,000 shares, increasing direct ownership by 124% to 433,923 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      12/26/24 6:25:08 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Officer Flomenberg Neal sold $1,747,332 worth of shares (1,078,600 units at $1.62), decreasing direct ownership by 20% to 4,254,302 units (SEC Form 4)

      4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)

      10/18/24 9:57:34 PM ET
      $TVGN
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care